Palvella Therapeutics, Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +46.2% | -89.2% | -54.3% | +1,069.0% | -32.5% | |
| – | – | – | – | – | – | – | +68.5% | -87.1% | -54.3% | +1,069.0% | -33.1% | |
| – | – | – | – | – | – | – | +67.2% | -86.4% | -54.2% | +1,037.4% | -30.6% | |
| – | – | – | – | – | – | – | +67.2% | -86.4% | -54.2% | +1,037.4% | -30.6% | |
| – | – | – | – | – | – | – | +94.2% | +75.4% | -100.0% | – | -100.0% | |
| – | – | – | – | – | – | – | +39.0% | -61.4% | -71.2% | +124.2% | +23.2% | |
| – | – | – | – | – | – | – | +128.3% | -88.6% | -59.2% | +410.1% | -5.8% | |
| – | – | – | – | – | – | – | +1.8% | -18.1% | – | – | – | |
| – | – | – | – | – | – | – | +381.8% | -63.1% | -70.6% | +390.0% | +0.2% | |
| – | – | – | – | – | – | – | +63.6% | -145.7% | – | – | -55.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +147.9% | +21.3% | +5.3% | +20.8% | -4.6% | +7.6% | +18.5% | +15.3% | +36.3% | +75.6% | +405.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.